Category Technical Cooperation/ Technology Transfer

UNICEF Supply Annual Report Highlights Medical Products Access, Innovation

In its recently released Supply Annual Report for 2012, the United Nations agency UNICEF assessed its programme work in developing and strengthening supply chains, in hopes of achieving equitable access to life-saving supplies for children and women. The report found that UNICEF procured supplies and services valued at $2.468 billion, with India being the largest supplier country to UNICEF in 2012.

Good Intentions Echo In Marrakesh At Start Of Negotiations On Treaty For The Blind

The World Intellectual Property Organization diplomatic conference expected to yield a treaty creating exceptions and limitations to copyright for the benefit of visually impaired people opened today in Marrakesh, Morocco.

Assurances of good faith and willingness to find solutions for remaining issues were given by delegates, while WIPO Director General Francis Gurry called for unity, King Mohammed VI talked about moral obligation in a royal message, and visually impaired people called for negotiators to create history. All nonetheless agreed on the importance of the copyright system.

Test Of Political Flexibility In Final Lap For WIPO Treaty For The Blind

Starting next week, Marrakesh, Morocco, will be the site of a two-week high level conference expected to yield a treaty facilitating the international access to books for blind and visually impaired people. Stakes are high, not only for the beneficiaries, but also for the industry worried that the copyright system might be endangered by the new treaty, introducing limitations to copyright.

To What Extent Can Global IP Rules Be Responsive To Public Interest Demands? The Case Of The Treaty For The Visually Impaired

To what extent can global intellectual property rules address in an effective manner the needs of the most vulnerable members of society? This is the key question with which member states of the World Intellectual Property Organization (WIPO) are faced as they prepare to meet next week for a diplomatic conference, in Marrakesh, that should result in the adoption of a treaty to facilitate access to copyrighted works by visually impaired persons and persons with print disabilities.

WHO Updates Guidance For Pandemic Flu Risk Management

The World Health Organization (WHO) has released an updated guidance document on pandemic influenza risk management, which includes the Pandemic Influenza Preparedness (PIP) Framework for the sharing of influenza viruses and access to vaccines and other benefits that was discussed by member states during the 66th World Health Assembly (WHA) in May.

WTO TRIPS Council: Discussion Of Innovation Shows Divergent Views; Tobacco Back On Agenda

The impact of intellectual property rights on the transfer of ‘green’ technology was brought up to the World Trade Organization committee on intellectual property this week with divided points of view. In addition, a discussion on cost-effective innovation was criticised by some developing countries as side-tracking the committee's objectives, and the European Union's planned revision of its tobacco products directive was disapproved by some producer countries.

WTO Members Agree On Draft Extension Of TRIPS Transition For LDCs

World Trade Organization members today reached a draft decision on a request put forward by least-developed countries to extend the period during which they do not have to comply with international rules of intellectual property rights protection, according to sources. Under the terms of the hard-fought decision, LDCs can benefit from an extension of eight more years.

Data From Clinical Trials Identify Gaps In Health R&D

Lower-income countries receive much less attention in terms of clinical trial research, according to a study published in this month’s World Health Organization (WHO) Bulletin. The study also underscored the value and importance the WHO International Clinical Trials Registry Platform (ICTRP) provides as a resource for evaluating the distribution of clinical trials around the world, and for providing information for future policy on health R&D.